The diabetes drug tirzepatide is associated with significant benefits for obese patients with obstructive sleep apnea (OSA), according to new research presented at the American Diabetes Associations 2024 Scientific Sessions and published in the New England Journal of Medicine .[1] Tirzepatide is sold by Eli Lilly and Company under the brand names Zepbound and Mounjaro
Private clinics are well aware of this gap, and so they have begun to market aggressively to international residents, often charging significantly higher, out-of-pocket prices
However, if this severe elevation is accompanied by symptoms such as chest pain, severe headache, shortness of breath, neurological symptoms, or confusion, patients should call 911 immediately as this represents a hypertensive emergency requiring urgent treatment
During this time, the body adjusts to the medication, and most patients experience a steady reduction in hunger and an improvement in their ability to control food intake
Just the peptide in the capsule
30 EnzN.VliegenG.De MeesterI.JungraithmayrW
